Analgesic use and ovarian cancer risk: an analysis in the Ovarian Cancer Cohort Consortium. JNCI 2018
Trabert B, Poole EM, White E et al
Breast cancer risk in relation to history of preeclampsia and hyperemesis gravidarum: Prospective analysis in the Generations Study. Int J Cancer. 2018; 143:782-792
Wright LB, Schoemaker MJ, Jones ME, Ashworth A, Swerdlow AJ
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation. Int J Cancer. 2018; 143:746-757
Abubakar M, Chang-Claude J, Ali HR et al
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Hum Mutat. 2018;39:729-741
Colombo M, Lòpez-Perolio I, Meeks HD, et al
Domestic light at night and breast cancer risk: a prospective analysis of 105 000 UK women in the Generations Study. Br J Cancer 2018;118:600-606
Johns LE, Jones ME, Schoemaker MJ, McFadden E, Ashworth A, Swerdlow AJ
Circulating Anti-Müllerian Hormone and Breast Cancer Risk: A Study in Ten Prospective Cohorts. Int J Cancer. 2018; 142:2215-2226
Ge W, Clendenen TV, Afanasyeva Y, et al
Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. Int J Epidemiol. 2018; 47:450-459
Ong JS, Hwang LD, Cuellar-Partida G, et al
BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res. 2017; 77:2789-2799
Shimelis H, Mesman RL, Von Nicolai C, et al
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Res. 2017; 19(1):119
Brouckaert O, Rudolph A, Laenen A, et al
Smoking and risk of breast cancer in the Generations Study cohort. Breast Cancer Res. 2017;19:118
Jones ME, Schoemaker MJ, Wright LB, Ashworth A, Swerdlow AJ
